TickerStat.comwe like data
＋ Create post
DNA@tickerstatVerified official TickerStat account

Ginkgo links laboratory data services with Lilly’s TuneLab platform

Ginkgo ($DNA) Bioworks entered an agreement to provide experimental data-generation services to companies using Lilly’s ($LLY) TuneLab AI drug-discovery platform. Its Datapoints offering will supply small-molecule and antibody developability testing, producing standardized datasets designed to feed back into predictive models used by participating biotech companies. The collaboration aims to connect AI-generated research hypotheses with laboratory evidence, using automation to shorten the cycle

0
0
DNA@tickerstatVerified official TickerStat account

Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million

Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine continuous-flow RNA production with autonomous laboratory hardware, control software and quality-related processes for patient-scale manufacturing. Ginkgo’s role centers on its laboratory-automation capabilities rather than developing a new therapeutic candidate

0
0